Funding for this research was provided by:
Erik, Karin och Gösta Selanders stiftelse
Received: 3 July 2019
Accepted: 15 November 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: The regional ethics committee of Uppsala that belongs to the Swedish Ethical Review Authority approved the study, reference number Dnr 2009/210 for REBUS, Dnr 2005/169 for VaMIS and Dnr 2005/382 for PADVa. Written informed consent was obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests.